Canadian Glycomics Network Presentation to JPIAMR March 28, 2017 www.glyconet.ca
Glycomics Multidisciplinary research area focusing on the role of carbohydrates (sugars or glycans) in biological systems. Platform technology that will provide novel solutions to unmet medical needs. 2
Canadian Glycomics Network (GlycoNet) A Networks of Centres of Excellence (NCE) Network and many other partners $27.25M (2015 – 2020) $11.3M (and growing) Two five-year renewals – up to 15 years of funding – are possible 3
GlycoNet Vision To deliver solutions to important health issues and to improve the quality of life of Canadians through glycomics. Multidisciplinary Research in Aggressive Knowledge and Glycomics Supported by Core Technology Exchange and Services Exploitation (KTEE) Strategy Synergistic Partnerships with Training the Next Generation Private Sector and of Glycomics Scientists and Government Laboratories Entrepreneurs 4
GlycoNet Institutions 110 Investigators (63) 26 Institutions (22) 7 Foundational Partners 5
Governance Condition for NCE Funding: GlycoNet must be a Canadian Not-for-Profit Corporation 6
Primary Roles of Committees • Evaluate and recommend research funding Research requests and new investigator applications Management Committee (RMC) • Develop research and management policies • Evaluate and recommend translational Commercialization funding requests Committee (CC) • Assist Management in research translation • Provide feedback on training initiatives Training • Approve student awards Committee • Advised by a trainee group 7
Primary Roles of Committees • Monitor Network spending and revenue generation Finance and Audit Committee • Vet and recommend Network budget developed by Management Nominating • Vet and recommend new members for Committee Board and committees • Act on behalf of the Board between Executive meetings Committee • Advise Management 8
External Input on Proposals • Provide feedback on research program to the RMC from investigator presentations at Scientific Advisory the Annual General Meeting (AGM) Board (SAB) • Review submitted proposals Ad Hoc Scientific • Review submitted proposals Reviewers • Provide feedback to the Commercialization Commercialization Committee on commercialization plans Plan Reviewers submitted by applicants 9
Policies and Procedures Terms of Conflict of Reference for Confidentiality Interest Committees Budget Environmental Reimbursement Carryover and Impact Reallocation Intellectual Proposal Project Property Review and Management Protection Appeal 10
Funding Mechanisms Collaborative Catalyst Translational Team Project Funding Project GlycoNet Innovation Continuum Early Stage Mature Opportunities for partnerships in all programs 11
Research and Development Funding • 40 Projects funded to date 14 Projects Chronic 7 Catalyst • $11.5M NCE funding Disease 6 Team • $5.4M Partner funding 1 Translation Core Services 10 Projects Rare Genetic 5 Projects Antimicrobials 1 Catalyst Diseases 1 Catalyst High- 8 Team Glycan 4 Team Throughput 1 Translation Screening Screening Glycan Glycan Structure Synthesis Analysis Therapeutic 9 Projects Diabetes & 2 Projects Proteins & 5 Catalyst Obesity 1 Team Vaccines 3 Team 1 Translation 1 Translation 12
Project Management Process Activity Calendar Month (starting with Fiscal Year) 4 5 6 7 8 9 10 11 12 1 2 3 Investigator Face-to-Face AGM Reporting (F-t-F) Update SAB SAB/ F-t-F Input to/from Report RMC evaluation to Committees to report RMC and to RMC to CC CC F-t-F Update Input to SAB/RMC/CC Evaluation and Investigators Evaluation RMC/CC Input Reporting to SAB/RMC/CC F-t-F Update Update Board Evaluation Evaluation 13
AGM & Symposium May 8 – 12, 2017 Banff Park Lodge, Banff, Alberta May 8 May 9 May 10 May 11 May 12 Morning AGM AGM Symposium Symposium Afternoon AGM AGM Workshop Symposium Evening AGM Symposium Symposium AGM • Presentations of funded projects to the SAB & RMC • Trainee Professional Development • Corporate Annual General Meeting Workshop • Immuno-oncology, lectures and panel discussion Symposium • Seven invited international speakers, 11 contributed talks • Posters (89 Abstracts submitted) • Anticipate 150+ Attendees 14
Opinions/Advice • If you don’t have to incorporate, don’t. – Extra costs (legal, insurance for the Board). – Extra bureaucracy to satisfy corporate government laws and regulations. • Don’t underestimate the amount of administrative support you will need. A good administrative team is worth the expense. • Although tedious, developing solid policies and procedures is essential and will simplify things later. 15
Recommend
More recommend
